Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.59M Buy
23,572
+1,155
+5% +$77K 0.02% 575
2026
Q1
$1.41M Buy
22,417
+2,809
+14% +$196K 0.02% 552
2025
Q4
$1.3M Sell
19,608
-10,687
-35% -$691K 0.02% 563
2025
Q3
$2.04M Sell
30,295
-18,910
-38% -$1.5M 0.03% 444
2025
Q2
$4.25M Buy
49,205
+1,753
+4% +$137K 0.08% 270
2025
Q1
$3.19M Buy
47,452
+6,294
+15% +$514K 0.06% 309
2024
Q4
$3.2M Buy
41,158
+5,123
+14% +$379K 0.06% 302
2024
Q3
$5M Sell
36,035
-1,775
-5% -$146K 0.13% 194
2024
Q2
$4.29M Buy
37,810
+1,775
+5% +$224K 0.1% 221
2024
Q1
$5M Buy
36,035
+3,017
+9% +$379K 0.13% 194
2023
Q4
$4.1M Buy
33,018
+2,026
+7% +$207K 0.12% 201
2023
Q3
$2.89M Sell
30,992
-1,580
-5% -$178K 0.1% 245
2023
Q2
$4.19M Buy
32,572
+4,766
+17% +$576K 0.16% 159
2023
Q1
$3.23M Buy
27,806
+1,534
+6% +$172K 0.13% 200
2022
Q4
$2.98M Sell
26,272
-1,672
-6% -$184K 0.16% 171
2022
Q3
$2.25M Buy
27,944
+3,155
+13% +$267K 0.15% 169
2022
Q2
$1.85M Buy
24,789
+2,721
+12% +$248K 0.13% 210
2022
Q1
$2.82M Buy
22,068
+6,700
+44% +$733K 0.19% 128
2021
Q4
$2.06M Buy
15,368
+11,036
+255% +$1.59M 0.16% 157
2021
Q3
$592K Buy
+4,332
New +$546K 0.06% 328

Other funds holding DXCM

Ethic Inc's DXCM Position: Q2 2026 in Review

Ethic Inc increased its DexCom (DXCM) stake by 5.2% in Q2 2026, buying an estimated $77K and bringing the position to 23,572 shares worth $1.59M. The position accounts for 0.02% of the portfolio, ranked #575.

Ethic Inc first reported a position in DXCM in Q3 2021 and has held it in 20 quarters since. The position peaked at $5M in Q3 2024. 307 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Ethic Inc held 23,572 shares of DexCom worth $1.59M as of Q2 2026.
  • Ethic Inc bought 1,155 DexCom shares in Q2 2026, an estimated $77K.
  • DexCom made up 0.02% of Ethic Inc's portfolio in Q2 2026, its #575 holding.
  • Ethic Inc first reported a position in DexCom in Q3 2021 and has held it in 20 quarters since.
  • Ethic Inc's DexCom position peaked at $5M in Q3 2024.
  • 307 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Ethic Inc's 13F filing for Q2 2026, filed 29 Jul 2026.